Cost Of Sales Cambiamento Data
AbbVie USD 4.28B 90M 2023-12
Acorda Therapeutics USD 3.06M 169K 2023-06
Agios Pharmaceuticals USD 586K 47K 2023-12
ALKERMES USD 61.51M 1.75M 2023-09
Alnylam Pharmaceuticals USD 85.86M 1.55M 2023-12
Amgen USD 3.11B 1.31B 2023-12
Biogen USD 618.3M 41.3M 2023-12
BioMarin Pharmaceutical USD 135.48M 10.73M 2023-12
Bluebird Bio USD 10.96M 1.39M 2023-09
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Eli Lilly USD 1.79B 72.1M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Incyte USD 64.05M 9.66M 2023-12
J&J USD 6.8B 418M 2023-12
Merck USD 3.34B 891M 2023-12
Moderna USD 929M 1.31B 2023-12
Neurocrine Biosciences USD 11.2M 300K 2023-09
Pfizer USD 6.66B 2.24B 2023-12
PTC Therapeutics USD 29.12M 19.62M 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Sarepta Therapeutics USD 37.03M 2.9M 2023-09
United Therapeutics USD 71M 900K 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



Gilead Sciences Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.